Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.600
+0.110 (4.42%)
Jul 24, 2026, 5:23 PM CET

STO:NEWBRY Cash Flow Statement

Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Other Adjustments
-20.55-18.42-13.89-17.86-13.64-4.95
Changes in Other Operating Activities
0.976.05-9.82-5.37-1.360.88
Operating Cash Flow
-19.58-12.37-23.71-23.23-15-4.07
Operating Cash Flow Growth
------
Investing Cash Flow
-0.88-2.21-2.95-0.86-24.4-26.74
Financing Cash Flow
23.4613.8433.44-0.7259.5943.95
Net Cash Flow
3.01-0.746.78-24.8120.1913.15
Free Cash Flow
-19.58-12.37-23.71-23.23-15-4.07
Free Cash Flow Growth
------
FCF Margin
-53.45%-36.16%-59.66%-207.96%-207.20%-143.17%
Free Cash Flow Per Share
-0.58-0.40-0.97-1.18-0.76-0.26
Levered Free Cash Flow
-25.95-17.83-25.23-24.8-16.03-4.68
Unlevered Free Cash Flow
-23.55-15.65-23.9-24.96-16.03-4.74